Maiwei Biotech said the FDA has formally authorized its clinical trial application for injectable 6MW5311 for hematologic malignancies, including chronic myelomonocytic leukemia (CMML) and multiple myeloma.

CSRC Shanghai bureau deputy director Zhao Guofu said at a Shanghai press briefing on June 12 that this year, the opening year of the '15th Five‑Year Plan', the CSRC will fully advance implementation of a new round of capital‑market reform and opening. He said regulators will further use the STAR Market as a testing ground, continue to strengthen the capital market’s inclusiveness, adaptability, attractiveness and competitiveness, and optimize full‑chain, full‑lifecycle financial services for technology firms to better support efforts to build a strong financial system and Chinese‑style modernization.

US President Trump said the maritime blockade will remain fully effective until an agreement is completed.